Oncology & Cancer

Nivolumab may induce successful depletion of HIV reservoir

(HealthDay)—Nivolumab treatment for non-small-cell lung cancer may induce successful depletion of HIV reservoir, according to a letter to the editor published online Dec. 1 in the Annals of Oncology.

Oncology & Cancer

70-gene signature impacts treatment decisions in breast CA

(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a study published online ...

Oncology & Cancer

New VTE often occurs during chemo in ovarian cancer

(HealthDay)—For patients with ovarian cancer, new diagnosis of venous thromboembolism frequently occurs during neoadjuvant or adjuvant chemotherapy, according to a study published in the June issue of Obstetrics and Gynecology.

Oncology & Cancer

ASCO updates recs on potentially curable pancreatic cancer

(HealthDay)—Guidelines relating to the appropriate adjuvant regimen for patients with pancreatic cancer have been updated in light of new evidence, according to a special article published online April 11 in the Journal ...

Obstetrics & gynaecology

pH-balanced vaginal gel doesn't improve dyspareunia

(HealthDay)—For breast cancer survivors who are premenopausal at diagnosis, a pH-balanced vaginal gel is no better than placebo for improving dyspareunia and overall sexual function, according to a study published in the ...

Oncology & Cancer

Chemo benefits patients after nephroureterectomy in UTUC

(HealthDay)—For patients undergoing radical nephroureterectomy (RNU) for pT3/T4 and/or pN+ upper tract urothelial carcinoma (UTUC), adjuvant chemotherapy (AC) use is associated with an overall survival benefit, according ...

page 4 from 9